Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 1/2015

01-01-2015 | Letter to the Editor

Salvage therapy with single agent L-asparaginase followed by local irradiation in an elderly patient with CD56-positve primary isolated extramedullary T-cell lymphoblastic lymphoma of the sinus

Authors: Daiki Hirano, Harumi Kato, Takeshi Kodaira, Yasushi Yatabe, Norihiro Ueda, Satsuki Murakami, Yusuke Higuchi, Hirofumi Taji, Shigeo Nakamura, Kazuhito Yamamoto, Tomohiro Kinoshita

Published in: Annals of Hematology | Issue 1/2015

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Thomas DA, O'Brien S, Cortes J, Giles FJ, Faderl S, Verstovsek S, Ferrajoli A, Koller C, Beran M, Pierce S, Ha CS, Cabanillas F, Keating MJ, Kantarjian H (2004) Outcome with the hyper-CVAD regimens in lymphoblastic lymphoma. Blood 104:1624–1630PubMedCrossRef
2.
No authors listed (1997) A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma classification project. Blood 89:3909–3918
3.
Sive JI, Buck G, Fielding A, Lazarus HM, Litzow MR, Luger S, Marks DI, McMillan A, Moorman AV, Richards SM, Rowe JM, Tallman MS, Goldstone AH (2012) Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trial. Br J Haematol 157:463–471PubMedCentralPubMedCrossRef
4.
Landsburg DJ, Stadtmauer E, Loren A, Goldstein S, Frey N, Nasta SD, Porter DL, Tsai DE, Perl AE, Hexner EO, Luger S (2013) Receipt of maintenance therapy is most predictive of survival in older acute lymphoblastic leukemia patients treated with intensive induction chemotherapy regimens. Am J Hematol 88:657–660PubMedCrossRef
5.
Hunault-Berger M, Leguay T, Thomas X, Legrand O, Huguet F, Bonmati C, Escoffre-Barbe M, Legros L, Turlure P, Chevallier P, Larosa F, Garban F, Reman O, Rousselot P, Dhedin N, Delannoy A, Lafage-Pochitaloff M, Bene MC, Ifrah N, Dombret H, Group for Research on Adult Acute Lymphoblastic L (2011) A randomized study of pegylated liposomal doxorubicin versus continuous-infusion doxorubicin in elderly patients with acute lymphoblastic leukemia: the GRAALL-SA1 study. Haematologica 96:245–252PubMedCentralPubMedCrossRef
6.
Hoelzer D, Gokbuget N, Digel W, Faak T, Kneba M, Reutzel R, Romejko-Jarosinska J, Zwolinski J, Walewski J (2002) Outcome of adult patients with T-lymphoblastic lymphoma treated according to protocols for acute lymphoblastic leukemia. Blood 99:4379–4385PubMedCrossRef
7.
Sakata K, Fuwa N, Kodaira T, Aratani K, Ikeda H, Takagi M, Nishio M, Satoh M, Nakamura S, Satoh H, Hareyama M (2006) Analyses of dose–response in radiotherapy for patients with mature T/NK-cell lymphomas according to the WHO classification. Radiother Oncol 79:179–184PubMedCrossRef
Metadata
Title
Salvage therapy with single agent L-asparaginase followed by local irradiation in an elderly patient with CD56-positve primary isolated extramedullary T-cell lymphoblastic lymphoma of the sinus
Authors
Daiki Hirano
Harumi Kato
Takeshi Kodaira
Yasushi Yatabe
Norihiro Ueda
Satsuki Murakami
Yusuke Higuchi
Hirofumi Taji
Shigeo Nakamura
Kazuhito Yamamoto
Tomohiro Kinoshita
Publication date
01-01-2015
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 1/2015
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-014-2128-7

Other articles of this Issue 1/2015

Annals of Hematology 1/2015 Go to the issue

Letter to the Editor

Hemophagocytic lymphohistiocytosis secondary to Falciparum malaria in a 5 year-old boy

Original Article

Association between low uric acid levels and acute graft-versus-host disease

Review Article

HMG-CoA reductase inhibitors as adjuvant treatment for hematologic malignancies: what is the current evidence?

Original Article

Impact of active surveillance, chlorambucil, and other therapy on health-related quality of life in patients with CLL/SLL in the Netherlands

Original Article

Diagnostic value of bronchoscopy in patients with hematologic malignancy and pulmonary infiltrates

Letter to the Editor

Invasive fungal infections after obinutuzumab monotherapy for refractory chronic lymphocytic leukemia
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits